Author

Zelda Mariet

Google (United States)ORCID 0009-0008-7199-2293Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Alex J. CornishiD· 1 shared Almoatazbellah YoussefiD· 1 shared Almudena Espín-PéreziD· 1 shared Anissa Martinez· 1 shared Anna Christina SchaariD· 1 shared Arndt HartmanniD· 1 shared Babak AlipanahiiD· 1 shared Benjamin W. JesteriD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alex J. CornishORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMar 13, 2026

Multi-modal benchmarking of the Ultima UG100 and Illumina NovaSeq sequencing platforms using clinically relevant FFPE tissues

Quentin Bayard, Zelda Mariet, Anna Christina Schaar…·Almudena Espín-Pérez

This paper benchmarks the Ultima UG100 and Illumina NovaSeq platforms on FFPE tissues for various sequencing modalities, finding they produce comparable results with subtle discrepancies in non-coding transcripts.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintDec 1, 2023

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2

Christof Angermueller, Zelda Mariet, Benjamin W. Jester…·Lucy J. Colwell

This study uses ML to design diverse VHH antibodies that neutralize SARS-CoV-1 and SARS-CoV-2 variants, including Delta and Omicron BA.1.

6 citations

machine learning (classical)drug response / drug discovery

𝕏 PostBluesky